Skip to main content
. Author manuscript; available in PMC: 2023 Aug 3.
Published in final edited form as: NEJM Evid. 2022 Dec 6;2(1):10.1056/evidoa2200131. doi: 10.1056/evidoa2200131

Figure 1. Consolidated Standards of Reporting Trials Flow Diagram for Enrollment in the OVERCOME Trial.

Figure 1.

*Includes four patients who received colistin in combination with imipenem. mITT denotes modified intention-to-treat; and OVERCOME, Colistin Monotherapy versus Combination Therapy.